Assessing the Performance of Prognostic Scores in Patients with Spinal Metastases from Lung Cancer Undergoing Non-surgical Treatment
Open Access
- 31 August 2023
- journal article
- research article
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 17 (4) , 739-749
Abstract
Study Design: Retrospective study.Purpose: The purpose of this study was to see how well the Tomita score, revised Tokuhashi score, modified Bauer score, Van der Linden score, classic Skeletal Oncology Research Group (SORG) algorithm, SORG nomogram, and New England Spinal Metastasis Score (NESMS) predicted 3-month, 6-month, and 1-year survival of non-surgical lung cancer spinal metastases.Overview of Literature: There has been no study assessing the performance of prognostic scores for non-surgical lung cancer spinal metastases.Methods: Data analysis was carried out to identify the variables that had a significant impact on survival. For all patients with spinal metastasis from lung cancer who received non-surgical treatment, the Tomita score, revised Tokuhashi score, modified Bauer score, Van der Linden score, classic SORG algorithm, SORG nomogram, and NESMS were calculated. The performance of the scoring systems was assessed by using receiver operating characteristic (ROC) curves at 3 months, 6 months, and 12 months. The predictive accuracy of the scoring systems was quantified using the area under the ROC curve (AUC).Results: A total of 127 patients are included in the present study. The median survival of the population study was 5.3 months (95% confidence interval [CI], 3.7–9.6 months). Low hemoglobin was associated with shorter survival (hazard ratio [HR], 1.49; 95% CI, 1.00–2.23; p =0.049), while targeted therapy after spinal metastasis was associated with longer survival (HR, 0.34; 95% CI, 0.21–0.51; p <0.001). In the multivariate analysis, targeted therapy was independently associated with longer survival (HR, 0.3; 95% CI, 0.17–0.5; p <0.001). The AUC of the time-dependent ROC curves for the above prognostic scores revealed all of them performed poorly (AUC <0.7).Conclusions: The seven scoring systems investigated are ineffective at predicting survival in patients with spinal metastasis from lung cancer who are treated non-surgically.Keywords
This publication has 28 references indexed in Scilit:
- Individual strategy for lung cancer patients with metastatic spinal cord compressionEuropean Journal of Surgical Oncology, 2016
- Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS)The Spine Journal, 2016
- Surgical results of metastatic spinal cord compression (MSCC) from non–small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complicationThe Spine Journal, 2016
- Modeling 1-year survival after surgery on the metastatic spineThe Spine Journal, 2015
- Preoperative palsy score has no significant association with survival in non-small-cell lung cancer patients with spinal metastases who undergo spinal surgeryJournal of Orthopaedic Surgery and Research, 2015
- Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)Journal of Thoracic Oncology, 2011
- Predictive value of seven preoperative prognostic scoring systems for spinal metastasesEuropean Spine Journal, 2008
- Prediction of survival in patients with metastases in the spinal columnCancer, 2005
- Survival after surgery for spinal and extremity metastases: Prognostication in 241 patientsActa Orthopaedica, 1995
- Scoring System for the Preoperative Evaluation of Metastatic Spine Tumor PrognosisSpine, 1990